Mechanistic Insights into Autophagy Modulation
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : University of Bern
Other organizations : University Hospital of Bern
Variable analysis
- Doxorubicin concentration (1 μM)
- Bafilomycin A1 (BafA) concentration (100 nM)
- Chloroquine (CQ) concentration (20 μM)
- Rapamycin concentration (200 nM)
- Leu-Leu methyl ester hydrobromide (LLOMe) concentration (0.001 to 1.4 mM)
- Sorafenib tosylate concentration (5 to 14 μM in vitro, 100 mg/kg in vivo)
- Cell response/viability (measured by MTT assay)
- Lipofectamine 3000 for plasmid DNA transfection
- FITC-dextran concentration (0.1 mg/mL)
- PBS composition (137 mM NaCl, 2.7 mM KCl, 12.5 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4)
- Low glucose DMEM lacking amino acids and serum for starvation
- Positive control: Overexpression of TFEB variant with pronounced nuclear localization characteristics in Huh-7 VTRNA1-1 KO cells
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!